Market revenue in 2023 | USD 1,359.1 million |
Market revenue in 2030 | USD 2,637.8 million |
Growth rate | 9.9% (CAGR from 2023 to 2030) |
Largest segment | Reagents & kits |
Fastest growing segment | Services |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Reagents & kits, Services, Instruments |
Key market players worldwide | Charles River Laboratories International Inc, BSL-BIOSERVICE Scientific Laboratories GmbH, Merck KGaA, Samsung BioLogics, Sartorius AG, Eurofins Scientific SE, SGS AG, Thermo Fisher Scientific Inc, BioMerieux SA, Lonza Group Ltd |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biological safety testing products and services market will help companies and investors design strategic landscapes.
Reagents & kits was the largest segment with a revenue share of 39.86% in 2023. Horizon Databook has segmented the U.S. biological safety testing products and services market based on reagents & kits, services, instruments covering the revenue growth of each sub-segment from 2018 to 2030.
The U.S. accounted for the largest share of over 86.5% of the North America biological safety testing market in 2015. The dominant share attained by this region is a consequence of unprecedented adoption rate of unhealthy lifestyles, which has led to high prevalence and incidence of diseases, such as cancer and diabetes.
The aforementioned factor serves as a significant contributing factor enabling wide scale drug development and their subsequent commercialization by major biopharmaceutical companies present across this region. This is further believed to engender a greater need to ensure high safety standards for specialized and targeted therapies and avert probable shortcomings.
Moreover, healthcare organizations, such as the U.S. FDA, and U.S. Department of Health and Human Services in collaboration with Centers for Disease Control and Prevention and National Institutes of Health, consistently strive to improve the biological and microbiological safety testing standards for biomedical laboratories through the formulation and enforcement of stringent regulatory guidelines.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. biological safety testing products and services market , including forecasts for subscribers. This country databook contains high-level insights into U.S. biological safety testing products and services market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account